The Claim
Elevated levels of midlife inflammatory markers, particularly high-sensitivity CRP, are predictive of slower gait speed and increased risk of mobility disability in late adulthood, independent of chronic disease status.
What the research says
Not yet evaluated
We are still looking at what the research says.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Adults with higher levels of a blood marker called high-sensitivity CRP in middle age have slower walking speed and a greater chance of losing mobility later in life, even if they do not have chronic diseases.
See the scientific wording
Elevated levels of midlife inflammatory markers, particularly high-sensitivity CRP, predict slower gait speed and increased risk of mobility disability decades later, even in individuals without chronic disease.
Persistent inflammation in midlife damages muscle tissue, weakens the connections between nerves and muscles, and reduces blood flow to muscles. This causes muscles to shrink, become weaker, and respond more slowly, making walking slower and more difficult decades later.
What the research says
1 studyPeople who have more inflammation in their 40s and 50s tend to walk slower and have more trouble moving when they get older, even if they’re otherwise healthy — and this study shows that inflammation is strongly linked to walking problems in older adults.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.